Table 2.
Characteristics | CAFs or MSCs | CSCs | Advantages of CAF targeting |
---|---|---|---|
Genotype | Relatively stable | Heterogeneous | More constant effects and less treatment failure |
Phenotype | Relatively stable | Highly dynamic and plastic | |
Density in tumor | High (especially in desmoplastic cancer) | Rare to low | Favorable pharmacodynamic effects |
Localization in tumor | Tumor periphery or surrounding blood vessels | Within tumor cell nests or at the invasive front | More accessible to therapeutics |